GIP Receptor Antagonist, SKL-14959 Indicated Alteration of the Lipids Metabolism to Catabolism by the Inhibition of Plasma LPL Activity, Resulting in the Suppression of Weight Gain on Diets-Induced…

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, March 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 4,787 followers.

Some more weekend reading: https://t.co/Sde7zYH0Ge

22 Jul 2023

Reply Repost Favourite

GIP Receptor Antagonist, SKL-14959 Indicated Alteration of the Lipids Metabolism to Catabolism by the Inhibition of Plasma LPL Activity, Resulting in the Suppression of Weight Gain on Diets-Induced Obesity Mice https://t.co/7VLk6urtTU https://t.co/KupfWgzL

17 Mar 2021

Reply Repost Favourite

[Full text] GIP receptor antagonist, SKL-14959, changed the lipids metab | DMSO @DovePress https://t.co/ga09XBpDgJ

09 Mar 2021

Reply Repost Favourite

Dove Medical Press

Article Metrics

GIP Receptor Antagonist, SKL-14959 Indicated Alteration of the Lipids Metabolism to Catabolism by the Inhibition of Plasma LPL Activity, Resulting in the Suppression of Weight Gain on Diets-Induced…

About this Attention Score

Mentioned by

Citations

Readers on